On March 26, the U.S. Supreme Court heard oral arguments in the FDA v. Alliance for Hippocratic Medicine (AHM), the case that could curtail access to mifepristone.
- Read about the facts of the case here and here.
- Read more about mifepristone here.
Here’s what you need to know:
-
Mifepristone will remain accessible without any potential medically unnecessary restrictions from the courts in states where abortion is legal until the Supreme Court rules on this case later this summer.
-
Mifepristone is safe, effective, and has been used by more than 5 million people in the United States for abortion and miscarriage care since the FDA approved it more than 20 years ago.
-
The Court should reject this politically motivated effort to interfere with the FDA’s approval process which has always been based on science and evidence.
-
Mifepristone has helped ensure that patients are able to make their own private medical decisions and has expanded access to reproductive health care — something that is under dire threat in
this country. -
No matter the outcome of this case, PPCWNY will continue to provide medication abortion at our health centers either using mifepristone or an alternative protocol.
If you have any questions, please contact us at [email protected].